Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model

Journal of Applied Microbiology

Volumn 114, Issue 2, 2013, Pages 509-515

  Boustanshenas, M ^a   Bakhshi, B ^a   Ghorbani, M ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Native vaccine; Rabbit; Recombinant CTB; Vibrio cholerae; WC rCTB

Indexed keywords

ANTIGENS; DISEASES; IMMUNIZATION; PURIFICATION; RECOMBINANT PROTEINS;

CHOLERA VACCINE; IMMUNOLOGICAL RESPONSE; NATIVE VACCINE; PURIFIED PROTEIN; RABBIT; RABBIT MODELS; RECOMBINANT CTB; VIBRIO CHOLERAE; WC-RECOMBINANT CTB; WHOLE CELL;

VACCINES;

BACTERIAL PROTEIN; CHOLERA VACCINE; GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT WHOLE CELL CHOLERA TOXIN B PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY; ANTIGEN; BACTERIUM; BIOTECHNOLOGY; CONCENTRATION (COMPOSITION); DISEASE RESISTANCE; DRUG DEVELOPMENT; EXPERIMENTAL STUDY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; LAGOMORPH; MEDICINE; PROTEIN; SERUM; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INOCULATION; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PURIFICATION; RABBIT; VIBRIO CHOLERAE; WESTERN BLOTTING;

ANIMALIA; ORYCTOLAGUS CUNICULUS; VIBRIO CHOLERAE;

EID: 84872421489     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12043     Document Type: Article

References (24)

1. Aliabad, N.H., Bakhshi, B., Pourshafie, M.R., Sharifnia, A. and Ghorbani, M. (2012) Molecular diversity of CTX prophage in Vibrio cholerae. Lett Appl Microbiol 55, 27-32.
2. Arêas, A.P.M., Oliveira, M.L.S., Ramos, C.R.R., Sbrogio-Almeida, M.E., Raw, I. and Ho, P.L. (2002) Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. Protein Expr Purif 25, 481-487.
3. Arêas, A.P.M., Oliveira, M.L.S., Miyaji, E.M., Leite, L.C.C., Aires, K.A., Dias, W.O. and Ho, P.L. (2004) Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice. Biochem Biophys Res Commun 321, 192-196.
4. Bakhshi, B. and Pourshafie, M.R. (2009) Assessing clonality of Vibrio cholerae strains isolated during four consecutive years (2004-2007) in Iran. Scand J Infect Dis 41, 256-262.
5. Bakhshi, B., Pourshafie, M.R., Navabakbar, F. and Tavakoli, A. (2008a) Genomic organisation of the CTX element among toxigenic Vibrio cholerae isolates. Clin Microbiol Infect 14, 562-568.
6. Bakhshi, B., Pourshafie, M.R., Navabakbar, F., Tavakoli, A., Shahcheraghi, F., Salehi, M., Faradjzadegan, Z. and Zahraei, S.M. (2008b) Comparison of distribution of virulence determinants in clinical and environmental isolates of Vibrio cholera. Iran Biomed J 12, 159-165.
7. Czerkinsky, C., Sun, J.B., Lebens, M., Li, B.L., Rask, C., Lindblad, M. and Holmgren, J. (1996) Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity. Ann NY Acad Sci 778, 185-193.
8. D'Ambrosio, A., Colucci, M., Pugliese, O., Quintieri, F. and Boirivant, M. (2008) Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation. J Leukoc Biol 84, 661-668.
9. Dukoral product monograph (2010). Canada, provided by Sanofi Pasteur Limited, last revised 2010; http://www1.ndmctsgh.edu.tw/pharm/pic/medinsert/005DUK01E.pdf.
10. Fontana, M.R., Monaci, E., Yanqing, L., Guoming, Q., Duan, G., Rappuoli, R. and Pizza, M. (2001) IEM101, a naturally attenuated Vibrio cholerae strain, as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 19, 75-85.
11. Levine, M.M. and Kaper, J.B. (1996) Cholera and Ecology of Vibrio cholerae; chapter 5. Chapman and Hall London: Academic Press, 125-186.
12. Liang, W., Wang, S., Yu, F., Zhang, L., Qi, G., Liu, Y., Gao, S. and Kan, B. (2003) Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Infect Immun 10, 5498-5504.
13. Roland, K.L., Cloninger, C., Kochi, S.K., Thomasa, L.J., Tinge, S.A., Rouskey, C. and Killeen, K.P. (2007) Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli. Vaccine 25, 8574-8584.
14. Rudin, A., Riise, G.C. and Holmgren, J. (1999) Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun 67, 2884-2890.
15. Ryan, E.T. and Calderwood, S.B. (2000) Cholera vaccines. Clin Infect Dis 31, 561-565.
16. Sanchez, J. and Holmgren, J. (1986) Recombinant system for over expression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci USA 86, 481-485.
17. Sharifnia, A., Bakhshi, B. and Pourshafie, M.R. (2012) wbeT sequence typing and IS1004 profiling of Vibrio cholerae isolates. Lett Appl Microbiol 54, 267-271.
18. Sun, J.B., Holmgren, J. and Czerkinsky, C. (1994) Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral tolerance. Proc Natl Acad Sci USA 91, 10795-10799.
19. Sun, J.B., Rask, C., Olsson, T., Holmgren, J. and Czerkinsky, C. (1996) Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 93, 7196-7201.
20. Taylor, D.N., Killeen, K.P., Hack, D.C., Kenner, J.R., Coster, T.S., Beattic, D.T., Ezzell, J., Hyman, T. et al. (1994) Development of a live, oral, attenuated vaccine against El Tor cholera. J Infect Dis 170, 1518-1523.
21. 1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model. Immunol Lett 68, 219-227.
22. Tuchikubo, K. and Yasuda, Y. (2000) Principles of mucosal immunity and development of mucosal vaccines using cholera toxin B subunit and its related adjuvants. Rec Res Dev Microbiol 4, 387-405.
23. Waldor, M.K. and Mekalanos, J.J. (1994) Vibrio cholerae O139 specific gene sequences. Lancet 343, 1366.
24. Yan, M., Liu, G., Diao, B., Qiu, H., Zhang, L., Liang, W., Gao, S. and Kanet, B. (2007) Vibrio cholerae serogroup O1 vaccine candidate against CTX ETΦ infection. Vaccine 25, 4046-4055.